logo
logo
Sign in

Ibuprofen API Market Projected to Reach Unprecedented Growth by 2029

avatar
Ganesh Shinde
Ibuprofen API Market Projected to Reach Unprecedented Growth by 2029

A new report by Future Market Insights (FMI) has revealed that the global Ibuprofen API market reached US$ 626.2 Million in 2022 and is projected to grow at a CAGR of 3% to reach US$ 772.2 Million by 2029. The market's expansion is driven by the ongoing need for low-cost nonsteroidal anti-inflammatory medicines (NSAID) and the size and age of manufacturing facilities.

The Ibuprofen API market's growth is being propelled by a variety of factors, including increasing API drug shortages and the establishment of a task force to address these issues, as well as the rise of cost-effective drug manufacturers in various countries and the supply of API drugs, mainly in developing nations.

The pharmaceutical API sector is facing significant supply and demand constraints for Ibuprofen API, with major producers halting output and a supply chain disruption in China exacerbated by decreased sales in India.

The volatility in Ibuprofen API is due to factors such as a smaller number of competitors, a lower utilization ratio, a lower margin level, new higher-value opportunities in complex combinations and high-grade API, the pace of FDA facility inspections, and ramping up production capacity through mergers and consolidation.

The increasing prevalence of various diseases, such as cardiovascular disease, infectious diseases, diabetes, and kidney-related problems, among all age groups worldwide, is pushing the demand for medication development and its market.

To identify better drug candidates, modern technologies such as high throughput, bioinformatics, and combinatorial chemistry have seen increased use. With the advancement of these technologies, drug development has become more sophisticated, accurate, and time-consuming. High-throughput screening is one of the most widely used drug discovery technologies due to automation, multi-detector readers, imaging gear, and software.

Leading Companies Profiled in Ibuprofen API Market are

  • BASF SE
  • BIOCAUSE Inc.
  • IOL Chemicals and Pharmaceuticals Limited
  • SI Group, Inc.
  • Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd.
  • Solara Active Pharma Sciences Limited
  • Granules India Limited

Read More@ https://www.futuremarketinsights.com/reports/ibuprofen-api-market

Key Segments of Ibuprofen API Industry Survey

Ibuprofen API Market by End User:

  • Contract Manufacturing Organizations
  • Pharmaceutical Companies


collect
0
avatar
Ganesh Shinde
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more